London – March 27, 2018 – Cooley advised GIC of Singapore on its investment in Oxford Nanopore Technologies as part of the £100 million raised from global investors, including China Construction Bank International, Hostplus and existing investors. Cooley London managing partner Justin Stock led the team advising GIC.
Oxford Nanopore has developed the world’s only portable, real-time DNA/RNA sequencer, the MinION. The funds raised will be used for the company’s expansion, including a new manufacturing facility in Oxford, UK, development of the global team and further research and development.
“Oxford Nanopore has a unique business model of providing accessible, real-time DNA-analysis technologies that can be applied to pocket-sized or industrial installations,” said Bryan Yeo, chief investment officer of public equities at GIC, in a news release. “This investment reflects our confidence in the global demand outlook for DNA information across many industries over the long term.”
GIC is a leading global investment firm established in 1981 to manage Singapore’s foreign reserves. It is a disciplined long-term value investor with more than $100 billion in assets in 40+ countries worldwide.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.